Table 3.
Estimation of cirrhosis prevalence rates by age group and projection to estimated cirrhosis prevalence in the US population.
| Age group (years) | Estimated number of patients with cirrhosis from APLD database | Total number of patients in APLD database | Estimated prevalence from APLD database (%) | Total US population (2018)∗ | 2018 US cirrhosis prevalence estimates | ||||
|---|---|---|---|---|---|---|---|---|---|
| Hospital claims | Medical claims | Hospital claims | Medical claims | Hospital claims | Medical claims | Hospital claims | Medical claims | ||
| 18–25 | 675 | 867 | 4,821,638 | 12,847,208 | 0.01 | 0.01 | 35,063,183 | 4909 | 2366 |
| 26–34 | 3582 | 4486 | 5,961,467 | 15,458,294 | 0.06 | 0.03 | 41,091,493 | 24,690 | 11,925 |
| 35–44 | 11,394 | 14,804 | 6,423,299 | 17,317,948 | 0.18 | 0.09 | 41,277,888 | 73,221 | 35,286 |
| 45–64 | 96,276 | 128,013 | 17,345,958 | 43,817,387 | 0.56 | 0.29 | 83,904,335 | 465,698 | 245,127 |
| ≥65 | 70,645 | 95,499 | 16,560,408 | 36,208,191 | 0.43 | 0.26 | 52,431,193 | 223,666 | 138,287 |
APLD: anonymized patient-level data. ∗US population stratified by age group available at https://www.worldometers.info/demographics/us-demographics/.